CADTH endorses that public drug programs reimburse Hemgenix for that treatment of hemophilia B if particular problems are achieved.Specialists mentioned that the amount of people predicted to acquire etranacogene dezaparvovec in another three years is uncertain and may be greater than estimated through the sponsor. Need to the overall quantity of i